ContentsIssue 131 • June 2023In association withCover StoryPathbreakers: The journey of first genericsInterviewAs RSV vaccine approvals loom, regulators devise vaccination strategiesFeatureManaged access programmes: Reaching patients in needIn DepthPathbreakers: The journey of first genericsManaged access programmes: Reaching patients in needInsulin pricing in flux as major pharma players take actionRSV vaccine approvals demand vaccination strategiesBuild API facilities in Central and Eastern Europe to fix drug shortagesBriefingNews in NumbersLatest NewsLatest DealsProject UpdatesIn DataM&A activity in the mining industryHiring activity in the mining industry decreasedPatent activity in the mining industry decreasedSentiment in the mining industry increasedThematic TakeCybersecurity in pharmaPowered by02/24/2024 05:15:16